These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29112657)

  • 21. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth.
    Ananth CV; Vintzileos AM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1557-63. PubMed ID: 17014813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based estimate of sibling risk for preterm birth, preterm premature rupture of membranes, placental abruption and pre-eclampsia.
    Plunkett J; Borecki I; Morgan T; Stamilio D; Muglia LJ
    BMC Genet; 2008 Jul; 9():44. PubMed ID: 18611258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.
    Fredriksen M; Peleikis DE
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):23-31. PubMed ID: 26404187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.
    Pozzi M; Carnovale C; Mazhar F; Peeters GGAM; Gentili M; Nobile M; Radice S; Clementi E
    J Clin Psychopharmacol; 2019; 39(4):386-392. PubMed ID: 31205193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of medication on intraocular pressure in children with attention deficit hyperactivity disorder: A prospective study.
    Guvenmez O; Cubuk M; Gunes S
    J Popul Ther Clin Pharmacol; 2020 May; 27(2):e45-e50. PubMed ID: 32379404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
    Schulz KP; Bédard AV; Fan J; Hildebrandt TB; Stein MA; Ivanov I; Halperin JM; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.
    van den Ban E; Souverein P; Swaab H; van Engeland H; Heerdink R; Egberts T
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):55-61. PubMed ID: 20166797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mode of conception, acompanying medical disorders and complications in the second half of pregnancy in women over the age of 35].
    Dakov T; Dimitrova V; Maseva A; Todorov T
    Akush Ginekol (Sofiia); 2014; 53(8):4-11. PubMed ID: 25672082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of ADHD treatment using methylphenidate and atomoxetine in the South African private healthcare sector.
    Munasur-Naidoo AP; Truter I
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):677-684. PubMed ID: 31456453
    [No Abstract]   [Full Text] [Related]  

  • 33. First trimester prediction of ischemic placental disease.
    Vintzileos AM; Ananth CV
    Semin Perinatol; 2014 Apr; 38(3):159-66. PubMed ID: 24836828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD.
    Ni HC; Lin YJ; Gau SS; Huang HC; Yang LK
    J Atten Disord; 2017 Jan; 21(1):27-39. PubMed ID: 23475825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Previous preeclampsia and risks of adverse outcomes in subsequent nonpreeclamptic pregnancies.
    Wikström AK; Stephansson O; Cnattingius S
    Am J Obstet Gynecol; 2011 Feb; 204(2):148.e1-6. PubMed ID: 21055722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prepregnancy low-plasma volume and predisposition to preeclampsia and fetal growth restriction.
    Scholten RR; Sep S; Peeters L; Hopman MTE; Lotgering FK; Spaanderman MEA
    Obstet Gynecol; 2011 May; 117(5):1085-1093. PubMed ID: 21508747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
    Fredriksen M; Halmøy A; Faraone SV; Haavik J
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA
    PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective Placentation Syndromes and Intellectual Disability in the Offspring: Nationwide Cohort and Sibling-Controlled Studies.
    Villamor E; Susser ES; Cnattingius S
    Am J Epidemiol; 2022 Aug; 191(9):1557-1567. PubMed ID: 35380610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions.
    Camacho X; Zoega H; Gomes T; Schaffer AL; Henry D; Pearson SA; Vigod S; Havard A
    Int J Epidemiol; 2023 Feb; 52(1):190-202. PubMed ID: 36135973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.